-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on WAVE Life Sciences, Raises Price Target to $30

Benzinga·12/09/2025 19:45:36
Listen to the news
Citigroup analyst Samantha Semenkow maintains WAVE Life Sciences (NASDAQ:WVE) with a Buy and raises the price target from $16 to $30.